CD34+ BM cells derived from CML patients secreted up to 10 times more VEGF, FGF-b, HGF, and IL-8 compared to normal donors' BM CD34+ cells. This evidence concerns the gene CXCL8 and chronic myelogenous leukemia, BCR-ABL1 positive.